Arcadia Biosciences Inc (RKDA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2023 | 06-2023 | 03-2023 | 12-2022 | 09-2022 | |
| Sales | 1,298 | 1,297 | 1,232 | -1,230 | 1,570 |
| Cost of Goods | 818 | 650 | 688 | -1,932 | 1,128 |
| Gross Profit | 480 | 647 | 544 | 702 | 442 |
| Operating Expenses | 2,695 | 2,751 | 5,099 | 1,380 | 4,561 |
| Operating Income | -1,397 | -1,454 | -3,867 | -1,610 | -3,991 |
| Other Income | 758 | 4,610 | -5,336 | 1,490 | 1,704 |
| Pre-tax Income | -639 | 3,156 | -9,203 | -120 | -2,287 |
| Income Tax | N/A | -1 | N/A | 13 | 1 |
| Net Income Continuous | -639 | 3,155 | -9,203 | -133 | -2,288 |
| Net Income Discontinuous | -1,928 | -2,337 | -181 | -4,195 | -589 |
| Minority Interests | N/A | -5 | N/A | -84 | -10 |
| Net Income | $-2,567 | $823 | $-9,384 | $-4,244 | $-2,867 |
| EPS Basic Total Ops | -1.89 | 0.61 | -10.86 | -6.08 | -4.67 |
| EPS Basic Continuous Ops | -0.47 | 2.33 | -10.65 | 1.19 | -3.71 |
| EPS Basic Discontinuous Ops | -1.42 | -1.71 | -0.21 | -7.02 | -0.96 |
| EPS Diluted Total Ops | -1.89 | 0.61 | -10.86 | -6.08 | -4.67 |
| EPS Diluted Continuous Ops | -0.47 | 2.33 | -10.65 | 1.19 | -3.71 |
| EPS Diluted Discontinuous Ops | -1.42 | -1.71 | -0.21 | -7.02 | -0.96 |
| EBITDA(a) | $-1,130 | $-1,210 | $-3,616 | $-994 | $-3,635 |